ISO 10993-5 Cytotoxicity — Extract Preparation & Interpretation
Cytotoxicity testing under ISO 10993-5 screens whether device extracts or materials harm cells in culture. It is a sensitive screening tool: extraction conditions and grading criteria drive the result, and a positive finding triggers investigation rather than automatic failure.
Fix the extraction conditions
Extraction vehicle, temperature, time and surface-area-to-volume ratio determine what the cells are exposed to. State the device's clinical contact so the laboratory can justify the conditions; a harsher extraction than clinical use can produce positives that need interpretation, while a milder one can miss relevant leachables. Agree the conditions in the protocol before testing.
Understand the readout
Qualitative morphological grading and quantitative assays (such as metabolic activity) answer the question differently. Ask which assay format is proposed, how grading is performed and controlled, and what positive and negative controls accompany the run. Borderline grades and assay interference by the test article should be addressed in the report.
Treat a positive as a starting point
A positive cytotoxicity result prompts identification of the cause — a material, residual or processing contaminant — and a risk-based assessment, not necessarily device rejection. Ask the laboratory what follow-up it can support (chemistry, retest with modified conditions) and how the result integrates into the biological evaluation.
Choose endpoints only when the exposure warrants them
Cytotoxicity, sensitization and irritation are distinct endpoints, not interchangeable safety conclusions. Blood-contacting applications may require hemocompatibility evaluation; systemic toxicity is a separate risk-based endpoint rather than a universal panel. Agree extraction conditions, test article preparation, controls and interpretation with the evaluator. A pass on one endpoint does not establish complete biological safety.
What to include in your buyer brief
Start with the decision the work must support. Unknown details can be clarified after the initial inquiry.
- Product, materials/formulation, patient or drug contact, contact duration, intended use and target market; identify changed materials, suppliers or processes.
- Finished configuration, sample count and lots, sterilization modality/cycles, aging and storage history; justify worst-case variants and destructive allocations.
- Existing evaluation plan, drawings, specifications, methods/editions, previous reports and acceptance criteria; send confidential files only through the private intake.
- Required report, quality/accreditation scope, budget range, location, shipping constraints and decision deadline; ask the provider to explain exclusions and subcontracted work.
Sample considerations
- Provide device/material details, surface area and intended clinical contact.
- State the required extraction conditions or ask for a justified proposal.
- Agree assay format, controls, acceptance criteria and investigation plan for positives.
Questions to ask a laboratory
- How are extraction conditions justified against our clinical use?
- Which assay format and grading controls apply?
- What follow-up is available if the screening result is positive?
Laboratories with relevant capabilities
No directory profile currently documents this specific capability. Submit a request and we will look for laboratories that cover it.
Frequently asked questions
- My device failed cytotoxicity — what now?
- Failures often trace to a residue rather than the base material. Laboratories commonly investigate by testing components separately, changing cleaning steps, or characterising the extract chemically to identify what is responsible.
- Can I test raw material instead of the finished device?
- Material screening is useful during development, but biological evaluation normally expects the final, finished, sterilised device because processing changes what can be released.
Sources and scope references
ISO 10993-5 — in-vitro cytotoxicity (catalogue entry)
Related testing briefs
Sensitization & Irritation Testing
chemical characterization medical devices
Packaging request coordination
Medical device request coordination
Confirm standard edition, jurisdiction and actual laboratory scope. Service references are not partnerships or endorsements.